The increasing morbidity and mortality associated with asthma may, in part, be due to inadequate treatment. Step-care management aims to improve control by addressing both the bronchospastic and inflammatory components of the disease.β-Adrenergic agonists are central to alleviating symptoms, whereas corticosteroids may reduce inflammation and associated airway hyper responsiveness.